German Watchdog Begins Probe Of $4B Fresenius-Rhoen Buy
The Federal Cartel Office, known domestically as Bundeskartellamt, said it would closely scrutinize the deal in order to ensure that it will not hinder competition in a way that affects patients.
“The Bundeskartellamt is closely examining the planned takeover,” the agency's president, Andreas Mundt, said in a statement. “The examination focuses particularly on...
To view the full article, register now.